Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3

被引:72
|
作者
Boyd, Scott [1 ]
Brookfield, Joanna L. [2 ]
Critchlow, Susan E. [1 ]
Cumming, Iain A. [2 ]
Curtis, Nicola J. [1 ]
Debreczeni, Judit [1 ]
Degorce, Sebastien L. [1 ]
Donald, Craig [1 ]
Evans, Nicola J. [3 ]
Groombridge, Sam [1 ]
Hopcroft, Philip [1 ]
Jones, Neil P. [3 ]
Kettle, Jason G. [1 ]
Lamont, Scott [1 ]
Lewis, Hilary J. [1 ]
MacFaull, Philip [1 ]
McLoughlin, Sheila B. [2 ]
Rigoreau, Laurent J. M. [2 ]
Smith, James M. [2 ]
St-Gallay, Steve [1 ]
Stock, Julie K. [3 ]
Turnbull, Andrew P. [3 ]
Wheatley, Edward R. [3 ]
Winter, Jon [1 ]
Wingfield, Jonathan [1 ]
机构
[1] AstraZeneca, Oncol Innovat Med Unit, Macclesfield SK10 4TG, Cheshire, England
[2] CRT Discovery Labs, Cambridge CB22 3AT, England
[3] UCL, Wolfson Inst Biomed Res, CRT Discovery Labs, London WC1E 6BT, England
关键词
KEY GLYCOLYTIC ENZYME; 6-PHOSPHOFRUCTO-2-KINASE PFKFB3; CANCER; PHOSPHOFRUCTOKINASE; EXPRESSION; FAMILY;
D O I
10.1021/acs.jmedchem.5b00352
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A weak screening hit with suboptimal physicochemical properties was optimized against PFKFB3 kinase using critical structure-guided insights. The resulting compounds demonstrated high selectivity over related PFKFB isoforms and modulation of the target in a cellular context. A selected example demonstrated exposure in animals following oral dosing. Examples from this series may serve as useful probes to understand the emerging biology of this metabolic target.
引用
收藏
页码:3611 / 3625
页数:15
相关论文
共 50 条
  • [1] Structure-Based Design of Potent and Selective Inhibitors of Pyruvate Carboxylase
    Schneider, Nicholas
    Burkett, Daniel
    Wyatt, Brittney
    Mews, Mallory
    Bautista, Anson
    Engel, Ryan
    Dockendorff, Chris
    Donaldson, William
    St Maurice, Martin
    [J]. PROTEIN SCIENCE, 2021, 30 : 141 - 141
  • [2] Structure-based design of potent and selective inhibitors of NF-κB inducing kinase (NIK)
    Blaquiere, Nicole
    Staben, Steven
    Castanedo, Georgette
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [3] Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
    Hu, Dennis X.
    Patel, Snahel
    Chen, Huifen
    Wang, Shumei
    Staben, Steven T.
    Dimitrova, Yoana N.
    Wallweber, Heidi Ackerly
    Lee, Joanna Y.
    Chan, Grace Ka Yan
    Sneeringer, Christopher J.
    Prangley, Madeleine S.
    Moffat, John G.
    Wu, Kai C.
    Schutt, Leah K.
    Salphati, Laurent
    Pang, Jodie
    McNamara, Erin
    Huang, Haochu
    Chen, Yong
    Wang, Yunli
    Zhao, Wensheng
    Lim, Junghyun
    Murthy, Aditya
    Siu, Michael
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, : 11500 - 11512
  • [4] Metabolic intervention targeting 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) using a structure-based design.
    Ahrlund-Richter, Lars
    Farnegardh, Katarina
    Wiita, Elisee
    Jonsson, Mattias
    Norstrom, Carina
    Martinsson, Jessica
    Hallberg, Kenth
    Ringom, Rune
    Mellstedt, Hakan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β
    Davies, Matthew P.
    Benitez, Rocio
    Perez, Concepcion
    Jakupovic, Sven
    Welsby, Philip
    Rzepecka, Klaudia
    Alder, Jane
    Davidson, Colin
    Martinez, Ana
    Hayes, Joseph M.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (03) : 1497 - 1509
  • [6] Structure-Based Design of Potent and Selective CK1γ Inhibitors
    Huang, Hongbing
    Acquaviva, Lisa
    Berry, Virginia
    Bregman, Howard
    Chakka, Nagasree
    O'Connor, Anne
    DiMauro, Erin F.
    Dovey, Jennifer
    Epstein, Oleg
    Grubinska, Barbara
    Goldstein, Jon
    Gunaydin, Hakan
    Hua, Zihao
    Huang, Xin
    Huang, Liyue
    Human, Jason
    Long, Alex
    Newcomb, John
    Patel, Vinod F.
    Saffran, Doug
    Serafino, Randy
    Schneider, Steve
    Strathdee, Craig
    Tang, Jin
    Turci, Susan
    White, Ryan
    Yu, Violeta
    Zhao, Huilin
    Wilson, Cindy
    Martin, Matthew W.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 1059 - 1064
  • [7] Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors
    Tao, Zhi-Fu
    Wang, Le
    Stewart, Kent D.
    Chen, Zehan
    Gu, Wendy
    Bui, Mai-Ha
    Merta, Philip
    Zhang, Haiying
    Kovar, Peter
    Johnson, Eric
    Park, Chang
    Judge, Russell
    Rosenberg, Saul
    Sowin, Thomas
    Lin, Nan-Horng
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) : 1514 - 1527
  • [8] Discovery and Structure-Activity Relationships of N-Aryl 6-Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors
    Boutard, Nicolas
    Bialas, Arkadiusz
    Sabiniarz, Aleksandra
    Guzik, Pawel
    Banaszak, Katarzyna
    Biela, Artur
    Bien, Marcin
    Buda, Anna
    Bugaj, Barbara
    Cieluch, Ewelina
    Cierpich, Anna
    Dudek, Lukasz
    Eggenweiler, Hans-Michael
    Fogt, Joanna
    Gaik, Monika
    Gondela, Andrzej
    Jakubiec, Krzysztof
    Jurzak, Mirek
    Kitlinska, Agata
    Kowalczyk, Piotr
    Kujawa, Maciej
    Kwiecinska, Katarzyna
    Les, Marcin
    Lindemann, Ralph
    Maciuszek, Monika
    Mikulski, Maciej
    Niedziejko, Paulina
    Obara, Alicja
    Pawlik, Henryk
    Rzymski, Tomasz
    Sieprawska-Lupa, Magdalena
    Sowinska, Marta
    Szeremeta-Spisak, Joanna
    Stachowicz, Agata
    Tomczyk, Mateusz M.
    Wiklik, Katarzyna
    Wloszczak, Lukasz
    Ziemianska, Sylwia
    Zarebski, Adrian
    Brzozka, Krzysztof
    Nowak, Mateusz
    Fabritius, Charles-Henry
    [J]. CHEMMEDCHEM, 2019, 14 (01) : 169 - 181
  • [9] Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)
    Kim, SH
    Pudzianowski, AT
    Leavitt, KJ
    Barbosa, J
    McDonnell, PA
    Metzler, WJ
    Rankin, BM
    Liu, R
    Vaccaro, W
    Pitts, W
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) : 1101 - 1106
  • [10] Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors
    Medina, Jesus R.
    Becker, Christopher J.
    Blackledge, Charles W.
    Duquenne, Celine
    Feng, Yanhong
    Grant, Seth W.
    Heerding, Dirk
    Li, William H.
    Miller, William H.
    Romeril, Stuart P.
    Scherzer, Daryl
    Shu, Arthur
    Bobko, Mark A.
    Chadderton, Antony R.
    Dumble, Melissa
    Gardiner, Christine M.
    Gilbert, Seth
    Liu, Qi
    Rabindran, Sridhar K.
    Sudakin, Valery
    Xiang, Hong
    Brady, Pat G.
    Campobasso, Nino
    Ward, Paris
    Axten, Jeffrey M.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1871 - 1895